Akcea and Ionis Pharmaceuticals shares made a solid gain on Monday after the companies announced positive top-line data for a midstage trial in patients with established cardiovascular disease and elevated levels of lipoprotein(a).
Clinical-stage biopharmaceutical company Kodiak Sciences expects to price 9 million shares for an initial public company valued up to more than $155 million.
Sears has been circling the drain for some time now, but with its most recent move it’s looking to stave off bankruptcy yet again.
Amazon is making the case for the connected home with its most recent offering of Alexa-related products. But does the home really need to be this connected? One analyst seems to think so.
Amarin shares absolutely skyrocketed on Monday after the company announced topline results from the Vascepa cardiovascular (CV) outcomes trial, REDUCE-IT. Needless to say, the results were very positive.
Pandora Media shares shot up early on Monday after it was announced that the company would be acquired by Sirius XM. The transaction is expected to close in the first quarter of 2019.
24/7 Wall St. has put together a preview of Conagra, Nike, Rite Aid and some other companies that are about to report their quarterly results.
Cannabis stocks had a huge showing on Wall Street this past week. In fact, most of the news flow was surrounding these stocks and how investors were pouring money into them.
With the markets at all-time highs, it is prime season for initial public offerings and companies can get more bang for their buck. There were a couple major IPOs this week that lived up…
Friday was a mixed day for the broad U.S. markets. The S&P 500 and the Dow each hitting new intraday all-time highs. Crude oil made a small gain in the session. The S&P 500…
Acadia Pharmaceuticals shares popped after the company announced that the FDA completed a postmarketing review and issued a clear statement reaffirming the positive benefit-risk profile of Nuplazid for patients with Parkinson’s disease psychosis.
GTx shares were absolutely crushed on Friday after the company announced results from its mid-stage trial in post-menopausal women with stress urinary incontinence.
United Natural Foods shares tumbled after it reported its most recent quarterly results after the markets closed on Thursday.
Micron released better-than-expected fiscal fourth-quarter financial results after the markets closed on Thursday.
Thursday was a very positive day for the broad U.S. markets with the S&P 500 and the Dow each hitting their all-time highs. Crude oil retreated slightly in the session. The S&P 500 sectors…
Eli Lilly spin-off Elanco Animal Health made a strong entrance to the market on Thursday.
Eventbrite entered the market with a bang on Thursday, at a more than a 56% premium to the set share price.
Micron is set to report its fiscal fourth-quarter financial results late on Thursday, and analysts are looking for strong growth on the top and bottom lines.
Under Armour shares made a solid gain on Thursday after the company announced a restructuring plan and a new full year outlook. As part of this restructuring the firm is also cutting about 400…
Adverum Biotechnologies shares made a handy gain on Thursday after the company announced a key update from the FDA.
